Novo Nordisk sued Hims and Hers Health on Monday over patent infringement after the U.S. telehealth firm launched, then ...

Patients wishing for an alternative to weight loss drug injections now have another option. The U.S. Food and Drug ...

We decided to exit the Oracle position and book a short-term tax loss, spreading the capital across several of the ...

How Low Is Too Low? (Downgrade, Technical Analysis) Novo Nordisk: Ugly Guidance, But Stock Refuses To Break Down Further Novo Nordisk: Full Kitchen Sink Reset Or Another Shoe Yet To Drop? Eli Lilly ...

It’s become clear that Big Pharma is not a friend of ordinary Americans. Prices are too high and have been rising for too ...

On February 9, Eli Lilly and Company (NYSE:LLY) announced an agreement to acquire Orna Therapeutics in a transaction valued ...

The Huntsville City Council is expected to finalize its agreement with Eli Lilly and Company on Thursday, bringing the largest private economic development project in state history to town.

Novo Nordisk A/S aims to start selling its weight-loss blockbuster Wegovy in vials, its latest move to win over customers ...

Novo and Lilly are locked in a tightening fight in the obesity-drug market, with Novo trying to win back its crown after a ...

Scientists are testing an entirely new way to fight heart disease: whether gene editing might offer a one-time fix for high ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… ...

The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but recent challenges have centered around protecting its market share.